Metoprolol Market Share in 2023
Determining the precise market share for metoprolol in 2023 is complex, as it involves numerous generic manufacturers and varying formulations. However, metoprolol remains a widely prescribed beta-blocker used to treat high blood pressure, chest pain, and heart failure. Its accessibility and efficacy contribute to its significant presence in the cardiovascular drug market.
What is Metoprolol Used For?
Metoprolol is a selective beta-1 adrenergic receptor blocker. It works by blocking the effects of epinephrine and norepinephrine on the heart and blood vessels. This results in a slower heart rate, reduced force of heart contractions, and vasodilation (widening of blood vessels), all of which help to lower blood pressure and reduce the heart's workload [1]. It is prescribed for conditions including hypertension, angina pectoris (chest pain), and to improve survival after a myocardial infarction (heart attack) [2].
Who Manufactures Metoprolol?
As a generic medication, metoprolol is produced by a large number of pharmaceutical companies globally. Major players in the generic drug market, such as Teva Pharmaceuticals, Mylan (now Viatris), and Aurobindo Pharma, are among the many manufacturers distributing metoprolol [3]. The market is characterized by intense competition among these generic producers.
When Does Metoprolol Patent Exclusivity Expire?
The patents for the original innovator metoprolol formulations have long expired. This has allowed for the widespread availability of generic versions of metoprolol tartrate and metoprolol succinate. The lack of patent protection on the active pharmaceutical ingredient means that competition is primarily driven by manufacturing efficiency and market access rather than proprietary drug development [4].
How Does Metoprolol Compare to Other Beta-Blockers?
Metoprolol belongs to a class of drugs known as beta-blockers. Within this class, metoprolol is a cardioselective beta-blocker, meaning it primarily affects beta-1 receptors found in the heart. Other beta-blockers may be non-selective (affecting both beta-1 and beta-2 receptors) or have additional properties, such as alpha-blocking activity. For instance, propranolol is a non-selective beta-blocker, while carvedilol is a non-selective beta-blocker with alpha-blocking effects [5]. The choice of beta-blocker depends on the patient's specific condition and individual response.
What are the Potential Side Effects of Metoprolol?
Common side effects of metoprolol can include fatigue, dizziness, slow heart rate (bradycardia), and cold extremities. Less common but more serious side effects may involve shortness of breath, depression, and erectile dysfunction [2]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Are There Alternatives to Metoprolol?
Yes, several alternative medication classes are used to treat conditions for which metoprolol is prescribed. These include other classes of antihypertensives like angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, and diuretics. For heart failure, other beta-blockers besides metoprolol are also used, as are medications like ACE inhibitors, ARBs, and ARNIs [6].
What is the Price of Metoprolol?
Due to its generic status, metoprolol is generally considered an affordable medication. The price can vary significantly depending on the dosage, form (immediate-release or extended-release), quantity, and the pharmacy where it is purchased. Generic metoprolol is available at much lower costs compared to brand-name medications [7].
Where Can I Find More Information on Drug Patents?
For detailed information on drug patents, including timelines and patent challenges, resources like DrugPatentWatch.com provide comprehensive data and analysis. You can explore their database to understand the patent landscape for various pharmaceutical products [4].
*
**Sources:
1. https://www.drugpatentwatch.com/drugs/metoprolol
2. https://www.nhs.uk/medicines/metoprolol/
3. https://www.fiercepharma.com/pharma/generic-drug-makers-face-pressure-from-all-sides
4. https://drugpatentwatch.com/
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703824/
6. https://www.heart.org/en/health-topics/heart-failure/treatment-plan/medications-for-heart-failure
7. https://www.goodrx.com/metoprolol